Co-Activation of STAT3 and YAP1 Signaling Pathways Limits EGFR Inhibitor Response in Lung Cancer

被引：0

作者：

Karachaliou, Niki ^{[1
]}

Chaib, Imane ^{[2
]}

Cardona, Andres ^{[3
]}

Lopez-Vivanco, Guillermo ^{[4
]}

Vergnenegre, Alain ^{[5
]}

Miguel Sanchez, Jose ^{[6
]}

Provencio, Mariano ^{[7
]}

De Marinis, Filippo ^{[8
]}

Passaro, Antonio ^{[8
]}

Carcereny, Enric ^{[9
]}

Reguart, Noemi ^{[10
]}

Garcia Campelo, Rosario ^{[11
]}

Santarpia, Mariacarmela ^{[12
]}

Viteri, Santiago ^{[1
]}

Molina Vila, Miguel Angel ^{[13
]}

Li, Xuefei ^{[14
]}

Zhou, Caicun ^{[15
]}

Moran, Teresa ^{[9
]}

Ramirez Serrano, Jose Luis ^{[2
,16
]}

Bivona, Trever ^{[17
]}

Ma, Patrick ^{[18
]}

Drozdowskyj, Ana ^{[19
]}

Cao, Peng ^{[20
]}

Rosell, Rafael ^{[21
]}

机构：

[1] Hosp Univ Quiron Dexeus, IOR, Barcelona, Spain

[2] Inst Invest Ciencies Germans Trias & Pujol, Lab Cellular & Mol Biol, Badalona, Spain

[3] Clin Country, Clin & Translat Oncol Grp, Bogota, Colombia

[4] Hosp Cruces, Baracaldo, Spain

[5] CHU Limoges, Limoges, France

[6] Hosp Univ La Princesa, Madrid, Spain

[7] Hosp Univ Puerta Hierro, Madrid, Spain

[8] European Inst Oncol, Div Thorac Oncol, Milan, Italy

[9] Catalan Inst Oncol Hospital Germans Trios & Pujol, Med Oncol, Badalona, Spain

[10] Hosp Clin Barcelona, Med Oncol, Barcelona, Spain

[11] Hosp Univ A Coruna, La Coruna, Spain

[12] Univ Messina, Oncol & Pathol, Messina, Italy

[13] Ior Quiron Dexeus Univ Inst, Pangaea Biotech Sl, Lab Cellular & Mol Biol, Barcelona, Spain

[14] Shanghai Pulm Hosp, Med Oncol, Shanghai, Peoples R China

[15] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Med Oncol, Shanghai, Peoples R China

[16] Catalan Inst Oncol, Lab Cellular & Mol Biol, Badalona, Spain

[17] UCSF, Med, San Francisco, CA USA

[18] Wvu Canc Inst, Morgantown, WV USA

[19] Pivotal Sl, Stat, Madrid, Spain

[20] Nanjing Univ Chinese Med, Hosp Integrated Tradit Chinese & Western Med, Lab Cellular & Mol Biol, Nanjing, Jiangsu, Peoples R China

[21] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

lung cancer; STAT3; signaling; EGFR Inhibitor; YAP1;

D O I：

10.1016/j.jtho.2016.11.1714

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.02b-047

引用

页码：S1216 / S1217

页数：2

共 50 条

[31] Erk1/2 activatiOn and modulation of STAT3 signaling in oral cancer
Gkouveris, Ioannis
Nikitakis, Nikolaos
Karanikou, Maria
Rassidakis, George
Sklavounou, Alexandra
ONCOLOGY REPORTS, 2014, 32 (05) : 2175 - 2182
[32] A novel STAT3 decoy inhibitor prevents lung cancer development
Njatcha, Christian
Wang, Jiayi
Li, Huiyu
Farooqui, Mariya
Siegfried, Jill M.
CANCER RESEARCH, 2019, 79 (13)
[33] Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer
Alexandrow, Mark G.
Song, Lanxi J.
Altiok, Soner
Gray, Jhanelle
Haura, Eric B.
Kumar, Nagi B.
EUROPEAN JOURNAL OF CANCER PREVENTION, 2012, 21 (05) : 407 - 412
[34] The Interaction of the IFNγ/JAK/STAT1 and JAK/STAT3 Signalling Pathways in EGFR-Mutated Lung Adenocarcinoma Cells
Han, Yaguang
Zhang, Yan
Tian, Ying
Zhang, Miao
Xiang, Cheng
Zhen, Qiang
Liu, Jiabao
Shang, Yanhong
Zhao, Yiyi
Si, Huarui
Sui, Aixia
JOURNAL OF ONCOLOGY, 2022, 2022
[35] MiR-205/YAP1 in Activated Fibroblasts of Breast Tumor Promotes VEGF-independent Angiogenesis through STAT3 Signaling
Du, Yan-e
Tu, Gang
Yang, Guanglun
Li, Genyou
Yang, Dan
Lang, Lei
Xi, Lei
Sun, Kexin
Chen, Yanlin
Shu, Kunxian
Liao, Huadong
Liu, Manran
Hou, Yixuan
THERANOSTICS, 2017, 7 (16): : 3972 - 3988
[36] EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer
Gong, Ke
Guo, Gao
Panchani, Nishah
Bender, Matthew E.
Gerber, David E.
Minna, John D.
Fattah, Farjana
Gao, Boning
Peyton, Michael
Kernstine, Kemp
Mukherjee, Bipasha
Burma, Sandeep
Chiang, Cheng-Ming
Zhang, Shanrong
Amod Sathe, Adwait
Xing, Chao
Dao, Kathryn H.
Zhao, Dawen
Akbay, Esra A.
Habib, Amyn A.
NATURE CANCER, 2020, 1 (04) : 394 - +
[37] EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer
Ke Gong
Gao Guo
Nishah Panchani
Matthew E. Bender
David E. Gerber
John D. Minna
Farjana Fattah
Boning Gao
Michael Peyton
Kemp Kernstine
Bipasha Mukherjee
Sandeep Burma
Cheng-Ming Chiang
Shanrong Zhang
Adwait Amod Sathe
Chao Xing
Kathryn H. Dao
Dawen Zhao
Esra A. Akbay
Amyn A. Habib
Nature Cancer, 2020, 1 : 394 - 409
[38] Alternative activation of STAT1 and STAT3 in response to interferon-γ
Qing, YL
Stark, GR
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) : 41679 - 41685
[39] Mutually exclusive activation of NFκB or STAT3 signaling pathways in multiple myeloma
Sebag, M.
Stewart, A. K.
Chng, W. J.
Keats, J.
Tiedemann, R.
Fonseca, R.
Bergsagel, P. L.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 98 - 98
[40] A novel lncRNA-mediated YAP1 signaling pathway activation in epithelial ovarian cancer
Lin, Xianzhi
Corona, Rosario I.
Gayther, Simon A.
Hazelett, Dennis L.
Lawrenson, Kate
CANCER RESEARCH, 2017, 77

← 1 2 3 4 5 →